This is a prospective cross-sectional study in which patients undergoing major pelvic reconstructive surgery with total vaginal hysterectomy will be recruited and enrolled. At approximately 2 weeks and 12 weeks postoperatively, enrolled patients will be asked to complete a survey detailing their experience with SDD, surgical recovery, and advice for prospective patients.

Inclusion Criteria:

• Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy
• Apical repair with uterosacral ligament suspension or sacrospinous ligament fixation
• They may also have any of the following concurrent procedures: Anterior repair, Posterior repair, Enterocele repair, Suburethral sling for incontinence
• Surgery by one of the fellowship trained urogynecologists at TriHealth
• English speaking

Exclusion Criteria:

• Enrollment in the "Diazepam Research Study" (Protocol ID:19-130)
• Concomitant procedure with another surgeon
• Chronic pain conditions that require daily use of narcotic pain medications (including but not limited to: chronic back or pelvic pain, interstitial cystitis, fibromyalgia)
• Concomitant anal sphincteroplasty, mesh removal or use of mesh for prolapse (excluding sling procedures)

All patients who underwent a total vaginal hysterectomy with concurrent vaginal native tissue prolapse repairs, including an apical suspension procedure performed by one of the fellowship trained urogynecologists at TriHealth.